Abdullah AlRabiah

Responsible for leading the entire oncology portfolio at the national level, developing strategic marketing plans, aligning with global priorities, and ensuring seamless execution across all regions. Overseeing cross-functional collaboration, performance tracking, and commercial optimization to drive sustainable growth and maximize market impact.

Key Responsibilities:

• Develop and lead national marketing strategies and tactical plans aligned with business objectives and growth priorities.
• Drive cross-functional collaboration to ensure unified execution.
• Align local plans with global strategies and ensure timely communication of market needs.
• Oversee the performance tracking of brand initiatives and campaigns, ensuring alignment with KPIs and revenue targets.
• Lead strategic planning for product positioning, pricing, and market access to strengthen competitive advantage.
• Manage and allocate marketing budgets effectively to maximize ROI and ensure optimal resource utilization.
• Identify new growth opportunities and lead launch readiness for pipeline and indication expansion.
• Represent the oncology line in business reviews and leadership meetings.
• Provide strategic guidance and training to sales teams and CFTs, while supporting execution to ensure a strong market presence.

• Demonstrate agility and adaptability by managing accounts across Central, Northern, and Eastern regions, navigating all healthcare sectors with precision and effectiveness.
• Prevent broker interference within both institutional and private sectors through skilled conflict resolution strategies, enhancing client satisfaction and streamlining processes to achieve targeted outcomes ahead of schedule.
• Cultivate strong, trust-based relationships with key stakeholders and decision-makers across the healthcare sector, positioning the company as a market leader in the region and expanding its influence in the territory.
• Implement comprehensive written treatment protocols for KFMC, KFSHD, and NGHR, ensuring alignment with best practices and regulatory standards while enhancing treatment options for healthcare providers.
• Led national and regional strategic initiatives beyond sales, directly collaborating with Medical, Market Access, and Regulatory Affairs.
• Develop strategic cross‑functional initiatives to reduce waste via near‑expiry stock reallocation and to elevate patient care through localized protocols based on global best practices across leading institutions.
• Provide pharmacoeconomic models to hospital administrators to support budget efficiency.

.

Key Achievements:

• Exceeds Expectations Recognition | 2025
• Best Achiever - Oncology & Hematology Line | 2024
• Best performer Recognition | 2024
• Best Achiever - Oncology & Hematology Line | 2022
• Best performer Recognition | 2022
• Best Achiever - Oncology & Hematology Line | 2021

• Built strong partnerships with cardiologists in the private sector and led the implementation of standardized treatment protocols across the largest private hospitals.
• Assigned as Lead Trainer for AZ Academy interns, managing onboarding, field coaching, business planning, and performance assessment.

Key Achievements:

• Best Achiever - Cardiovascular Disease Line | MEA Region | 2020
• Far Exceeds Expectations Recognition | 2020